Hims & Hers Health (HIMS) Competitors $62.57 -3.61 (-5.45%) Closing price 03:59 PM EasternExtended Trading$62.52 -0.05 (-0.08%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, and PRVAShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Its Competitors Natera Fresenius Medical Care AG & Co. KGaA Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.24% compared to Natera's net margin of -10.36%. Hims & Hers Health's return on equity of 22.75% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-10.36% -18.29% -11.68% Hims & Hers Health 9.24%22.75%15.51% Do insiders and institutionals hold more shares of NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B10.83-$190.43M-$1.47-91.55Hims & Hers Health$1.48B9.49$126.04M$0.6990.68 Which has more volatility & risk, NTRA or HIMS? Natera has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Do analysts rate NTRA or HIMS? Natera currently has a consensus target price of $183.76, suggesting a potential upside of 36.55%. Hims & Hers Health has a consensus target price of $39.83, suggesting a potential downside of 36.34%. Given Natera's stronger consensus rating and higher possible upside, equities research analysts clearly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Does the media favor NTRA or HIMS? In the previous week, Hims & Hers Health had 34 more articles in the media than Natera. MarketBeat recorded 70 mentions for Hims & Hers Health and 36 mentions for Natera. Natera's average media sentiment score of 1.00 beat Hims & Hers Health's score of 0.39 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 21 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 14 Very Positive mention(s) 1 Positive mention(s) 50 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHims & Hers Health beats Natera on 9 of the 16 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$14.81B$2.04B$5.48B$20.69BDividend YieldN/AN/A4.74%3.67%P/E Ratio90.6833.7928.6529.07Price / Sales9.4913.29438.0057.24Price / Cash187.9256.2135.4522.84Price / Book28.978.978.274.43Net Income$126.04M-$62.31M$3.24B$994.22M7 Day Performance8.82%-8.15%-3.56%-3.97%1 Month Performance30.71%2.24%5.89%-1.14%1 Year Performance237.85%18.23%23.18%7.36% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.5368 of 5 stars$62.57-5.5%$39.83-36.3%+211.6%$14.81B$1.48B90.681,637Trending NewsUpcoming EarningsInsider TradeGap DownNTRANatera3.708 of 5 stars$140.61+1.2%$183.76+30.7%+30.5%$19.23B$1.70B-95.804,434Trending NewsInsider TradeFMSFresenius Medical Care AG & Co. KGaA3.5067 of 5 stars$25.86-2.2%$27.80+7.5%+31.0%$15.18B$19.49B23.091,384Positive NewsGHGuardant Health4.5692 of 5 stars$44.43+0.0%$54.45+22.6%+16.7%$5.51B$739.02M-13.112,021Trending NewsEarnings ReportAnalyst ForecastOPCHOption Care Health4.6309 of 5 stars$29.78+0.3%$35.50+19.2%-1.1%$4.88B$5.00B24.038,088News CoveragePositive NewsEarnings ReportAnalyst ForecastRDNTRadNet4.0624 of 5 stars$57.72+0.5%$69.60+20.6%-8.4%$4.34B$1.83B-134.3611,021Positive NewsBTSGBrightSpring Health Services2.7157 of 5 stars$20.45-0.4%$24.90+21.8%+66.7%$3.59B$11.27B73.0235,000News CoverageEarnings ReportGap DownSHCSotera Health2.4294 of 5 stars$12.33+0.2%$16.00+29.8%-17.2%$3.50B$1.10B154.213,000Upcoming EarningsSGRYSurgery Partners2.7489 of 5 stars$22.27+4.7%$33.33+49.7%-27.7%$2.85B$3.17B-14.5515,000Positive NewsUpcoming EarningsGap UpCONConcentra Group Holdings Parent2.8529 of 5 stars$19.93+1.3%$28.50+43.0%-14.5%$2.55B$1.93B14.8711,250Upcoming EarningsPRVAPrivia Health Group3.7743 of 5 stars$19.74+0.1%$28.38+43.8%-5.9%$2.41B$1.74B164.441,140Upcoming Earnings Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors CON Competitors PRVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMusk's Big Prediction for 2025Elon Musk just made a bold prediction about 2025—and it could upend the entire tech sector. If he’s right, ...The Oxford Club | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
